Brief: Fibrobiologics Announces Reverse Stock Split To Regain Compliance With Nasdaq’S Bid Price Requirement
25/03/2026 20:31
March 25 (Reuters) - Fibrobiologics Inc FBLG.O: FIBROBIOLOGICS ANNOUNCES REVERSE STOCK SPLIT TO REGAIN COMPLIANCE WITH NASDAQ’S BID PRICE REQUIREMENT FIBROBIOLOGICS INC - BOARD APPROVES 1-FOR-20 REVERSE STOCK SPLIT Source text: ID:nGNX33wB86 Further company coverage: FBLG.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fibrobiologics
See all newsBrief: Fibrobiologics Files Patent Application For Technology Designed To Produce Glp-1 And Other Therapeutic Peptides Inside The Body
Brief: Fibrobiologics Announces Chondrocyte Spheroids Demonstrate Cartilage Repair In Preclinical Study Of Degenerative Joints
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil
U.S. STOCKS ON THE MOVEX-Abbott, Columbia Financial, Jabil,
Brief: Fibrobiologics Granted US Patent Covering The Use Of Fibroblasts